Adherence in HIV type 1 prevention trials.
Jared M
JM
Baeten
D000212:Acyclovir / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D005260:Female; D015658:HIV Infections / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*; D015497:HIV-1; D006558:Herpes Genitalis / Q000150:complications / Q000188:drug therapy; D018258:Herpesvirus 2, Human / Q000187:drug effects; D006801:Humans; D010349:Patient Compliance; D016032:Randomized Controlled Trials as Topic / Q000379:methods / Q000592:standards; D013636:Tanzania
D000998:Antiviral Agents; D000212:Acyclovir